Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc.（AVIR）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · AVIR · 截至 2026年6月8日
活动摘要
买入笔数
4
P-Purchase only
卖出笔数
1
近12个月
买卖比
4.00
Buy/Sell (by trades)
整体情绪
Atea Pharmaceuticals, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
AVIR 季度内部人买卖趋势
AVIR 内幕交易卖出 · AVIR 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · AVIR CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
AVIR 高管卖出股份 · AVIR 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 18, 2025 | Murphy Polly A. Director | Purchase | 6,100 | $25K | Form 4 |
| Mar 11, 2026 | Corcoran Andrea See Remarks | Option | 60,000 | $74K | Form 4 |
| Jan 31, 2026 | Horga Maria Arantxa Chief Medical Officer | Option | 51,283 | — | Form 4 |
| Jan 31, 2026 | Horga Maria Arantxa Chief Medical Officer | Other | 16,073 | $68K | Form 4 |
| Jan 31, 2026 | Vavricka John Chief Commercial Officer | Option | 42,083 | — | Form 4 |
| Jan 31, 2026 | Vavricka John Chief Commercial Officer | Other | 11,570 | $49K | Form 4 |
| Jan 31, 2026 | Hammond Janet MJ Chief Development Officer | Option | 58,050 | — | Form 4 |
| Jan 31, 2026 | Hammond Janet MJ Chief Development Officer | Other | 14,136 | $60K | Form 4 |
| Jan 31, 2026 | Corcoran Andrea See Remarks | Option | 54,866 | — | Form 4 |
| Jan 31, 2026 | Corcoran Andrea See Remarks | Other | 16,104 | $68K | Form 4 |
| Feb 3, 2026 | Sommadossi Jean-Pierre President, CEO, and Chairman · Director | Option | 300,000 | $372K | Form 4 |
| Jan 31, 2026 | Sommadossi Jean-Pierre President, CEO, and Chairman · Director | Option | 272,983 | — | Form 4 |
| Jan 31, 2026 | Sommadossi Jean-Pierre President, CEO, and Chairman · Director | Other | 106,093 | $450K | Form 4 |
| Jan 31, 2026 | Foster Wayne EVP, Chief Accounting Officer | Option | 41,333 | — | Form 4 |
| Jan 31, 2026 | Foster Wayne EVP, Chief Accounting Officer | Other | 12,132 | $51K | Form 4 |
| Jun 20, 2025 | Murphy Polly A. Director | Option | 29,600 | — | Form 4 |
| Jun 20, 2025 | BERGER FRANKLIN M Director | Option | 29,600 | — | Form 4 |
| Jun 20, 2025 | Duncan Barbara Gayle Director | Option | 29,600 | — | Form 4 |
| Jun 20, 2025 | Polsky Bruce Director | Option | 29,600 | — | Form 4 |
| Jun 20, 2025 | Adams Jerome M. Director | Option | 29,600 | — | Form 4 |
| Jun 20, 2025 | Lucidi Bruno Director | Option | 29,600 | — | Form 4 |
| Jan 31, 2025 | Hammond Janet MJ Chief Development Officer | Award | 11,250 | — | Form 4 |
| Jan 31, 2025 | Hammond Janet MJ Chief Development Officer | Option | 46,800 | — | Form 4 |
| Jan 31, 2025 | Hammond Janet MJ Chief Development Officer | Other | 14,134 | $43K | Form 4 |
| Jan 31, 2025 | Vavricka John Chief Commercial Officer | Award | 8,750 | — | Form 4 |
Sommadossi Jean-Pierre
President, CEO, and Chairman · Director
日期
Feb 3
股数
300,000
均价
$1.24
总金额
$372K
Sommadossi Jean-Pierre
President, CEO, and Chairman · Director
日期
Jan 31
股数
272,983
均价
—
总金额
—
Sommadossi Jean-Pierre
President, CEO, and Chairman · Director
日期
Jan 31
股数
106,093
均价
$4.24
总金额
$450K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AVIR 内幕交易
AVIR 内幕交易
Atea Pharmaceuticals, Inc.（AVIR）内幕交易数据来源于公司内部人（包括Corcoran Andrea (See Remarks), Sommadossi Jean-Pierre (President, CEO, and Chairman · Director), Horga Maria Arantxa (Chief Medical Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。AVIR内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Atea Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
AVIR 内幕交易 · 5个问题Atea Pharmaceuticals, Inc.（AVIR）的内部人包括高管和董事，如Corcoran Andrea (See Remarks), Sommadossi Jean-Pierre (President, CEO, and Chairman · Director), Horga Maria Arantxa (Chief Medical Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026